Free Trial

4D pharma (LBPSW) Competitors

LBPSW vs. ATNFW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, CALA, and CELUW

Should you be buying 4D pharma stock or one of its competitors? The main competitors of 4D pharma include 180 Life Sciences (ATNFW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), Calithera Biosciences (CALA), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

4D pharma vs.

4D pharma (NASDAQ:LBPSW) and 180 Life Sciences (NASDAQ:ATNFW) are both manufacturing companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership, community ranking and valuation.

Company Net Margins Return on Equity Return on Assets
4D pharmaN/A N/A N/A
180 Life Sciences N/A N/A N/A

4D pharma and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
4D pharmaN/AN/A
180 Life SciencesN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
4D pharma$522KN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

In the previous week, 4D pharma's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
4D pharma Neutral
180 Life Sciences Neutral

Summary

4D pharma beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Remove Ads
Get 4D pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for LBPSW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LBPSW vs. The Competition

Metric4D pharmaPharmaceutical Preparation Manufacturing IndustryManufacturing SectorNASDAQ Exchange
Market CapN/AN/A$1.97B$7.16B
Dividend YieldN/AN/A2.66%4.06%
P/E RatioN/AN/A23.2917.50
Price / SalesN/AN/A63.3385.03
Price / CashN/AN/AN/A34.64
Price / BookN/AN/A1.773.82
Net IncomeN/AN/A-$389.14M$247.19M

4D pharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A-18.8%$0.00N/A0.007Positive News
AEHAW
Aesther Healthcare Acquisition
N/A$0.03
-4.1%
N/A-91.8%$0.00N/A0.002Gap Up
AIMDW
Ainos
N/A$0.11
-8.3%
N/A+54.6%$0.00$20,729.000.0040Positive News
Gap Down
ALVOW
Alvotech
N/A$1.40
-7.3%
N/A-57.6%$0.00$489.68M0.004Positive News
Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
flat
N/A-42.9%$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.06
-36.2%
N/A+107.7%$0.00$37.32M0.0070Positive News
Gap Down
BTMDW
biote
N/A$0.06
-2.4%
N/A-86.1%$0.00$197.19M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.10
-0.1%
N/A-91.6%$0.00N/A0.008Positive News
Gap Down
CALA
Calithera Biosciences
N/A$0.00
-83.3%
N/A-99.5%$0.00N/A0.0060Analyst Forecast
Gap Down
CELUW
Celularity
N/A$0.04
-2.4%
N/A-15.6%$0.00$48.20M0.00220Positive News
Gap Down
Remove Ads

Related Companies and Tools


This page (NASDAQ:LBPSW) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners